Volume 49 | Number 6 | December 2014

Abstract List

Aaron J. Dawes M.D., Rachel Louie M.S., David K. Nguyen M.D., Melinda Maggard‐Gibbons M.D., M.S.H.S., Punam Parikh M.P.H., Susan L. Ettner Ph.D., Clifford Y. Ko M.D., M.S., M.S.H.S., David S. Zingmond M.D., Ph.D.


To examine the effect of Medicaid enrollment on the diagnosis, treatment, and survival of six surgically relevant cancers among poor and underserved Californians.

Data Sources

California Cancer Registry (), California's Patient Discharge Database (), and state Medicaid enrollment files between 2002 and 2008.

Study Design

We linked clinical and administrative records to differentiate patients continuously enrolled in Medicaid from those receiving coverage at the time of their cancer diagnosis. We developed multivariate logistic regression models to predict death within 1 year for each cancer after controlling for sociodemographic and clinical variables.

Data Collection/Extraction Methods

All incident cases of six cancers (colon, esophageal, lung, pancreas, stomach, and ovarian) were identified from . records were linked to hospitalizations () and monthly Medicaid enrollment.

Principal Findings

Continuous enrollment in Medicaid for at least 6 months prior to diagnosis improves survival in three surgically relevant cancers. Discontinuous Medicaid patients have higher stage tumors, undergo fewer definitive operations, and are more likely to die even after risk adjustment.


Expansion of continuous insurance coverage under the Affordable Care Act is likely to improve both access and clinical outcomes for cancer patients in alifornia.